Trials / Completed
CompletedNCT03350386
Drug-drug Interaction Study of FYU-981 and Oxaprozin
Drug-drug Interaction Study to Evaluate the Pharmacokinetics and Safety of FYU-981 and Oxaprozin in Healthy Male Adults Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Mochida Pharmaceutical Company, Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This is an open-label, 2-period add-on study to assess the drug-drug interaction between FYU-981 and oxaprozin. The purpose of this study is to investigate the pharmacokinetics of each period in a single administration of FYU-981 and concomitant administration of FYU-981 with oxaprozin at steady -state in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FYU-981 | Single administration |
| DRUG | Oxaprozin | Repeated administration |
Timeline
- Start date
- 2017-11-02
- Primary completion
- 2017-12-05
- Completion
- 2017-12-05
- First posted
- 2017-11-22
- Last updated
- 2022-09-14
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03350386. Inclusion in this directory is not an endorsement.